Skip to main content
SpringerLink
Log in

Identification and Treatment of Anaemia in Older Patients

  • Review Article
  • Published:
Drugs & Aging Aims and scope Submit manuscript

Summary

Anaemia in elderly patients should never be regarded as a normal physiological response to aging. Underlying causes must be investigated and treated in a similar manner to that used in younger adults. In addition to a thorough history and physical examination, basic investigations such as red cell indices and morphology, reticulocyte count, haematinic assays and occasionally bone marrow examination, will detect the underlying pathology in most cases.

Anaemia may be classified, according to red blood cell mean corpuscular volume, into microcytic, macrocytic and normocytic types. Anaemia with an absolute reticulocytosis is due either to acute blood loss or haemolysis. Other anaemias, more frequently encountered in elderly patients, are hypoproliferative, and reflect depressed marrow production or impaired erythroid maturation. Examples include anaemia of chronic disease and iron deficiency and, less commonly, megaloblastic anaemia and anaemia due to primary bone marrow failure.

The treatment of anaemia should aim to correct the underlying cause of the disorder and/or to improve the quality of the blood, e.g. by haematinic replacement therapy. Recombinant human erythropoietin has revolutionised the treatment of anaemia associated with chronic renal failure, while its role in other anaemias is currently under investigation. Regular blood transfusion may be required for some elderly patients with chronic anaemia. However, the attendant risks of this procedure, such as iron overload and viral hepatitis transmission, must be considered.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Auerbach M, Witt D, Toler W, Fierstein M, Lerner RG, et al. Clinical use of the total dose intravenous infusion of iron dextran. Journal of Laboratory and Clinical Medicine 111: 566–570, 1988

    PubMed  CAS  Google Scholar 

  • Bell CA, Zwicker J, Sacks HJ. Autoimmune hemolytic anemia: routine serologic evaluation in a general hospital population. American Journal of Clinical Pathology 60: 903, 1973

    PubMed  CAS  Google Scholar 

  • Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, et al. Proposals for the classification of the myelodysplastic syndromes. British Journal of Haematology 51: 189–199, 1982

    PubMed  CAS  Google Scholar 

  • Bessman JD, Gilmer Jr PR, Gardner FH. Improved classification of anaemias by MCV and RDW. American Journal of Clinical Pathology 80: 322–326, 1983

    PubMed  CAS  Google Scholar 

  • Cartwright GE, Deiss A. Sideroblasts, siderocytes and sideroblastic anemia. New England Journal of Medicine 292: 185–193, 1975

    Article  PubMed  CAS  Google Scholar 

  • Cazzola M, Ponchio L, Beguin Y, Rosti V, Bergamaschi G, et al. Subcutaneous erythropoietin for treatment of refractory anaemia in haemolytic disorders. Results of a phase I/II clinical trial. Blood 79: 29–37, 1992

    PubMed  CAS  Google Scholar 

  • Challand GS, Michalloudis A, Watfa RR, Coles SJ, Macklin JL. Distribution of haemoglobin in patients presenting to their general practitioner and its correlation with serum ferritin. Annals of Clinical Biochemistry 27: 15–20, 1990

    PubMed  Google Scholar 

  • Chanarin I. Megaloblastic anaemia, cobalamin and folate. Journal of Clinical Pathology 40: 978, 1987

    Article  PubMed  CAS  Google Scholar 

  • Chanarin I. Pernicious anaemia. Diagnosis should be certain before treatment is begun. British Medical Journal 304: 1584–1585, 1992

    Article  PubMed  CAS  Google Scholar 

  • Cook JD. Clinical evidence of iron deficiency. Seminars in Hematology 19: 6–18, 1982

    PubMed  CAS  Google Scholar 

  • Douglas SW, Adamson JW. The anaemia of chronic disorders: studies of marrow regulation and iron metabolism. Blood 45: 55–65, 1975

    PubMed  CAS  Google Scholar 

  • Eschbach JW, Egrie JC, Downing MR, Browne JK, Adamson JW. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin: results of a combined phase I and II clinic trial. New England Journal of Medicine 316: 73–78, 1987

    Article  PubMed  CAS  Google Scholar 

  • Fairbanks VF, Wahner HW, Phyliky RL. Tests for pernicious anemia: the ‘Schilling test’. Mayo Clinical Proceedings 58: 541–544, 1983

    CAS  Google Scholar 

  • Hoffbrand AV, Wickremasinghe RG. Megaloblastic anaemia. Recent Advances in Haematology 3: 22–44, 1982

    Google Scholar 

  • Htoo MS, Kofkoff RL, Freedman ML. Erythrocyte parameters in the elderly: an argument against new geriatric normal ranges. Journal of the American Geriatrics Society 27: 547–551, 1979

    PubMed  CAS  Google Scholar 

  • Hutchinson RM, Winfield DA. Mitozantrone and cytosine arabinoside as first line therapy in elderly patients with acute myeloid leukaemia. British Journal of Haematology 80: 416–417, 1992

    Article  PubMed  CAS  Google Scholar 

  • Kelly A, Munan L. Haematological profile of natural populations: red cell parameters. British Journal of Haematology 35: 153–160, 1977

    Article  PubMed  CAS  Google Scholar 

  • Kirkeby OJ, Fossum S, Riscoe C. Anaemia in elderly patients. Incidence and causes of low haemoglobin concentration in a city general practice. Scandinavian Journal of Primary Health Care 9: 167–171, 1991

    Article  PubMed  CAS  Google Scholar 

  • Kruger A. The limits of normality in elderly patients. Ballieres Clinical Haematology 1: 271–289, 1987

    Article  CAS  Google Scholar 

  • Lee GR. The anaemia of chronic disease. Seminars in Hematology 20: 61–80, 1983

    PubMed  CAS  Google Scholar 

  • Lipschitz DA, Mitchell CO, Thompson C. The anaemia of senescence. American Journal of Hematology 11: 47–54, 1981

    Article  PubMed  CAS  Google Scholar 

  • Liu Yin JA, Johnson PRE, Davies JM, Flanagan NG, Gurst DW, et al. Mitozantrone and cytosine arabinoside as first line therapy in elderly patients with acute myeloid leukaemia. British Journal of Haematology 79: 415–420, 1991

    Article  PubMed  CAS  Google Scholar 

  • Ludwig H, Fritz E, Kotzmann H, Hocker P, Gisslinger H, et al. Erythropoietin treatment of anaemia associated with multiple myeloma. New England Journal of Medicine 322: 1693–1699, 1990

    Article  PubMed  CAS  Google Scholar 

  • MacLennan ICM, Chapman C, Dunn J, Kelly K. Combined chemotherapy with ABCM versus melphalan for treatment of myelomatosis. Lancet 339: 200–205, 1992

    Article  PubMed  CAS  Google Scholar 

  • Means RT, Krantz SB. Progress in understanding the pathogenesis of the anaemia of chronic disease. Blood 80: 1639–1647, 1992

    PubMed  Google Scholar 

  • Milne JS, Williamson J. Haemoglobin, haematocrit, leucocyte count and blood grouping in older people. Geriatrics 27: 118–122, 1972

    PubMed  CAS  Google Scholar 

  • Mufti GJ, Galton DAG. Myelodysplastic syndromes: natural history and features of prognostic importance. Clinics in Haematology 15: 953–971, 1986

    PubMed  CAS  Google Scholar 

  • Nardone DA, Roth KM, Mazur DJ, McAfee JH. Usefulness of physical examination in detecting the presence or absence of anaemia. Archives ofInternal Medicine 150: 201–204, 1990

    Article  CAS  Google Scholar 

  • Oster W, Herrmann F, Ganm H, Zeile G, Lindemann A, et al. Erythropoietin for the treatment of anaemia of malignancy associated with neoplastic bone marrow infiltration. Journal of Clinical Oncology 8: 956–962, 1990

    PubMed  CAS  Google Scholar 

  • Pincus T, Olsen NJ, Russell IJ, Wolfe F, Harris ER, et al. Multicentric study of recombinant human erythropoietin in correction of anemia in rheumatoid arthritis. American Journal of Medicine 89: 161–168, 1990

    Article  PubMed  CAS  Google Scholar 

  • Pippard MJ, Callander ST. The management of iron chelation therapy. British Journal of Haematology 54: 503–507, 1983

    Article  PubMed  CAS  Google Scholar 

  • Rees JKH, Gray RG, Swirsky D, Hayhoe FGJ. Principal results of Medical Research Council’s 8th acute myeloid leukaemia trial. Lancet 2: 1236–1241, 1986

    Article  PubMed  CAS  Google Scholar 

  • Savage D, Lindenbanm J. Anaemia in alcoholics. Medicine 65: 322–338, 1986

    Article  PubMed  CAS  Google Scholar 

  • Sjoblom S-M, Sipponen P, Miettinen M, Karonen S-K, Jarvinen HJ. Gastroscopic screening for gastric carcinoids and carcinomas in pernicions anaemia. Endoscopy 20: 52–58, 1988

    Article  PubMed  CAS  Google Scholar 

  • Worlledge SM. Immune drug induced hemolytic anemias. Seminars in Hematology 10: 327, 1973

    PubMed  CAS  Google Scholar 

  • Zaino EC. Blood counts in the nonogenarian. New York State Journal of Medicine 81: 1199–1200, 1981

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Haematology, Leicester Royal Infirmary, Leicester, LE1 5WW, England

    Philip T. Murphy &  Robert M. Hutchinson

Authors
  1. Philip T. Murphy
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Robert M. Hutchinson
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Murphy, P.T., Hutchinson, R.M. Identification and Treatment of Anaemia in Older Patients. Drugs & Aging 4, 113–127 (1994). https://doi.org/10.2165/00002512-199404020-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002512-199404020-00004

Keywords

Search

Navigation